Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 6, 2014, Pages 638-642

  Oliveira, Isabela S ^a   Cabral, Milena S ^a   Jesus, Larissa S ^a   Paraná, Raymundo ^a   Atta, Ajax M ^a   Sousa Atta, Maria Luiza B ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

B cell polyclonal activation; Chronic hepatitis C; Cryoglobulin; Free light chain

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA FREE LIGHT CHAIN; IMMUNOGLOBULIN LAMBDA FREE LIGHT CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; BRAZIL; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; BLOOD; CASE CONTROL STUDY; CHRONIC HEPATITIS C; COMPLICATION; IMMUNOHISTOCHEMISTRY; MIDDLE AGED;

CASE-CONTROL STUDIES; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 84926118846     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2014.07.007     Document Type: Article

References (23)

1. Ramos-Casals M., Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 2005, 17:447-455.
2. Ramos-Casals M., Stone J.H., Cid M.C., Bosch X. The cryoglobulinaemias. Lancet 2012, 379:348-360.
3. Gisbert J.P., García-Buey L., Pajares J.M., Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003, 125:1723-1732.
4. Ferri C., Antonelli A., Mascia M.T., et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007, 39(Suppl. 1):S13-S21.
5. Marcucci F., Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011, 117:1792-1798.
6. Inokuchi M., Ito T., Uchikoshi M., et al. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C. J Med Virol 2009, 81:619-627.
7. Zignego A.L., Giannini C., Gragnani L. HCV and lymphoproliferation. Clin Dev Immunol 2012, 10.1155/2012/980942.
8. Forghieri F., Luppi M., Barozzi P., et al. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. Clin Dev Immunol 2012, 2012:807351. 10.1155/2012/807351.
9. Visentini M., Conti V., Cristofoletti C., et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev 2013, 12:430-435.
10. Dispenzieri A., Kyle R., Merlini G., et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009, 23:215-224.
11. Hutchison C.A., Landgren O. Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation. Clin Chem 2011, 57:1387-1389.
12. Charafeddine K.M., Jabbour M.N., Kadi R.H., Daher R.T. Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review. Am J Clin Pathol 2012, 137:890-897.
13. Bradwell A.R., Carr-Smith H.D., Mead G.P., et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001, 47:673-680.
14. Terrier B., Sène D., Saadoun D., et al. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Ann Rheum Dis 2009, 68:89-93.
15. Geri G., Terrier B., Semoun O., et al. Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis. Ann Rheum Dis 2010, 69:2177-2180.
16. Atta A.M., Oliveira I.S., Sousa G.M., Paraná R., Atta M.L. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies. Microb Pathog 2010, 48:53-56.
17. Atta M., Cabral M., Santos G., Paraná R., Atta A. Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia. Inflamm Res 2012, 61:1101-1106.
18. Okazaki T., Nagai T., Kanno T. Gel diffusion procedure for the detection of cryoglobulins in serum. Clin Chem 1998, 44:1558-1559.
19. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
20. Katzmann J.A., Clark R.J., Abraham R.S., et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002, 48:1437-1444.
21. Andrade L.J., Melo P.R., Atta A.M., et al. Smooth muscle antibodies and cryoglobulinemia are associated with advanced liver fibrosis in Brazilian hepatitis C virus carriers. Braz J Infect Dis 2011, 15:66-68.
22. Martin W., Abraham R., Shanafelt T., et al. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Transl Res 2007, 149:231-235.
23. Landgren O., Goedert J.J., Rabkin C.S., et al. Circulating serum free light chains as predictive markers of AIDS-related lymphoma. J Clin Oncol 2010, 28:773-779.